Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.78 | 8.32 |
| PEG Ratio (TTM) | -0.17 | -22.49 |
| P/S Ratio (TTM) | 0.20 | 1.21 |
| P/B Ratio (TTM) | 0.88 | 1.40 |
| P/FCF Ratio (TTM) | 3.21 | 12.29 |
| Price to 5YR AVG Earnings Ratio | 79.84 | 21.76 |
| Price to 5YR AVG FCF Ratio | 4.18 | 4.21 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -8.96% | 4.65% |
| ROE (TTM) | -23.88% | 15.15% |
| Net Profit Margin (TTM) | -5.35% | 11.63% |
| ROIC 5YR AVG | 10.84% | 9.27% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -144.53% | 658.84% | 350.51% |
| Revenue | -16.63% | 46.19% | 36.03% |
| Net Income | -143.55% | 681.54% | 364.25% |
| Cash Flow | 165.06% | 32.45% | 22.26% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.04 | 0.88 |
| Quick Ratio (TTM) | 3.04 | 0.84 |
| D/E Ratio (TTM) | 0.88 | 1.15 |
| Interest Coverage (TTM) | -0.14 | -2.11 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.51 | 1.11 |
| LTL to 5YR AVG FCF | 4.32 | 7.64 |
| Shares Outstanding Growth 5YR AVG | -0.50% | 7.67% |